Press & News

2019-02-22

Solna, Sweden, February 22, 2019. Affibody Medical AB (“Affibody”), a clinical stage biopharmaceutical company...[read more]

Financial Calendar

2018

August
Interim Report Q2 – August 23, 2018

November
Interim Report Q3 – November 16, 2018

Affibodys latest Press releases

2019-02-22

Affibody Announces Fully Guaranteed Rights Issue

Solna, Sweden, February 22, 2019. Affibody Medical AB (“Affibody”), a clinical stage biopharmaceutical company developing a pipeline of innovative...[read more]

Press & News

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

About Affibody

Upcoming reports Financial calendar

Interim Report Q2 (August 23, 2018)

Investor information